Partner Headlines - ILMN

  1. Celgene, Alexion Beat Estimates, But Biotechs Fall

    IBD
  2. Stock Indexes Nearly Flat, But Apparel, Paper, Internet Shine

    IBD
  3. Under Armour, Facebook Soar As Nasdaq Turns Positive

    IBD
  4. Illumina reports robust Q2

    IBD
  5. Stocks Open Low And Soft; Baidu, Kandi, Diamonback Rise

    IBD
  6. Facebook, Gilead Headline IBD 50's Top 5 Earnings

    IBD
  7. Illumina Names Tina S. Nova As Senior Vice Pres And General Manager ...

    Benzinga
  8. Some Stock Leaders Stay Firm Amid Pullback

    IBD
  9. Several Big Cap 20 Names Near Buy Points

    IBD
  10. Albany Molecular's Oso Buy Seen Boosting Earnings

    IBD
  11. Salix, Jazz Lead As Drugmakers Pace IBD 50 For Week

    IBD
  12. Stocks Mixed In Late Trade, But Growth Stocks Outperform

    IBD
  13. Nasdaq Showing Outperformance; GoPro Extends Gains

    IBD
  14. Novo, Other Medicals Display Healthy Action

    IBD
  15. 3 Hot Biotech Stocks Hitting Highs

    Benzinga
  16. Facebook Pops, But Key Indexes End Flat In Quiet Session

    IBD
  17. A Few Medical Research Stocks Break Out, Others Basing

    IBD
  18. Stocks Hold Near Highs; Illumina Breakout Gains Traction

    IBD
  19. Stocks Build On Gains Backed By Strong Volume

    IBD
  20. Stocks Show Solid Gains At Midday

    IBD
  21. Stocks Reverse Into Thin Losses; Joy Global, Illumina Rocket

    IBD
  22. Five Star Biotech Stock Watch: Illumina

    Benzinga
  23. Baron Funds Comments on Illumina Inc.

    GuruFocus
  24. Baron Funds Comments on Illumina Inc.

    GuruFocus
  25. Valeant, Tesla Working On Bases As Energy Dominates

    IBD
  26. Baron Funds Comments on Illumina Inc.

    GuruFocus
  27. Nasdaq Recovers After Early Weakness; Apple Rallies Again

    IBD
  28. Illumina Reports Filing of New Patent Infringement Case Against ...

    Benzinga
  29. Gilead, Illumina Q1 Earnings Win Wall Street's Love

    IBD
  30. Stock Futures Mixed And Busy; Illumina Rockets, Cree Tumbles

    IBD
  31. Gilead, Illumina Crush Views

    IBD
  32. Stocks Rise In Higher Volume; Gilead Up After Hours

    IBD
  33. Stocks Rise; Valeant, Netflix Soar After Hours

    IBD
  34. Analyst Bullish On Medical Research, Equipment Stocks

    IBD
  35. How To Tweak Your Retirement Portfolio For 2014 Market

    IBD
  36. Medical Research Providers Ride Higher With Biotechs

    IBD
  37. Illumina, Alexion Lead 4 Big Caps Drawing Big Buyers

    IBD
  38. Gap-Ups Point To Strength Among Select Big Caps

    IBD
  39. Illumina Inc: How Long Can a Miracle Go On?

    GuruFocus
  40. LinkedIn, TripAdvisor, Google: Top Manager's Ideas

    IBD
  41. Facebook, Biogen, Sands Among Top Big Caps Reporting

    IBD
  42. ILLUMINA

    IBD
  43. Illumina, Jazz Among 5 Young Guns Hitting New Highs

    IBD
  44. Illumina Details Its Strategy; Stock Jumps Again

    IBD
  45. US Stock Futures Surge Ahead Of Morgan Stanley Earnings

    Benzinga
  46. Illumina Announces New Organizational Alignment -8K

    Benzinga
  47. Market Wrap For January 16: Markets End Two Day Winning Streak

    Benzinga
  48. ILLUMINA

    IBD
  49. Illumina Upbeat On Q4, 2014

    IBD
  50. Illumina, Regeneron, Intuitive Q4 Results Impress

    IBD
  51. Year in Review: 2013 Innovations

    FoxBusiness
  52. Year in Review: 2013 Innovations

    FoxBusiness
  53. Benzinga's Top Initiations

    Benzinga
  54. Illumina Receives FDA Premarket Clearance for MiSeqDx System

    Benzinga
  55. Gilead Sciences Leads In Rising Short Interest Among Biotechs ...

    Benzinga
  56. Illumina Appoints Francis deSouza as President

    Benzinga
  57. Syntrix Biosystems Announces Court Upholds $115M Patent Infringement ...

    Benzinga
  58. Vipshop, 3D Systems Lead Top 5 Outperforming Stocks

    IBD
  59. Illumina Signs Agreement to Acquire NextBio, Leader in Analyzing ...

    Benzinga
  60. Short Sellers Retreat From Biogen Idec, Move On Pharmacyclics ...

    Benzinga
  61. Illumina Hits New High As HiSeq Yields Record Quarter

    IBD
  62. Illumina Announces TruGenome Undiagnosed Disease Test

    Benzinga
  63. Illumina Tops Q3 Profit, Sales

    IBD
  64. Illumina Earnings, Guidance Beat Estimates Yet Again

    IBD
  65. Earnings Scheduled For October 21, 2013

    Benzinga
  66. Illumina Collaborates with University of Cambridge, Genomics ...

    Benzinga
  67. Illumina's Verinata Health Reports Expanded Test of Verifi for ...

    Benzinga
  68. Short Sellers Move On Amgen, Vertex (AMGN, PCYC, VRTX)

    Benzinga
  69. BioMarin, Celgene Lead Trend in Biotech Short Interest (BRMN, ...

    Benzinga
  70. Illumina Applies CE Mark to Expanded MiSeqDx™ System

    Benzinga
  71. Illumina's Verinata Reports Non-invasive Verifi Prenatal Test2 ...

    Benzinga
  72. Alexion, Pharmacyclics Buck Trend in Biotech Short Interest (ALXN, ...

    Benzinga
  73. UPDATE: Wells Fargo Initiates Coverage on Illumina on Prime Market ...

    Benzinga
  74. Sony and Illumina Set to Change the Way Doctors Identify and ...

    Benzinga
  75. Illumina to Supply Natera with Sequencing Instruments, Consumables ...

    Benzinga
  76. Drug R&D Suppliers Deliver

    IBD
  77. Medical Research Firms Tap Drug Development Trend

    IBD
  78. Medical Research Firms Tap Drug Development Trend

    IBD
  79. Short Interest In Celgene, Onyx Continues To Shrink (CELG, ONXX, ...

    Benzinga
  80. Illumina, Grifols, Acadia Resist The Correction

    IBD
  81. Benzinga's M&A Chatter for Monday August 12, 2013

    Benzinga
  82. Baron Funds Comments on Illumina Inc.

    GuruFocus
  83. Baron Funds Comments on Illumina Inc.

    GuruFocus
  84. PerkinElmer Stock Hits 12-Year High After Q2 Beat

    IBD
  85. Short Interest in Pharmacyclics Plunges (AMGN, ONXX, PCYC)

    Benzinga
  86. Education Companies Another Market Leader

    IBD
  87. Short Interest Swings in Biotech Stocks (AMGN, CELG, ONXX)

    Benzinga
  88. UPDATE: Illumina Posts Higher Q4 Profit

    Benzinga
  89. Biogen MS Hopes Trump EPS

    IBD
  90. Stocks Turn Mixed, Apple Rises; Stratasys, 3D Systems Tumbling

    IBD
  91. Earnings Scheduled For January 28, 2013

    Benzinga
  92. Short Interest Swings in Biotech Stocks (BIIB, CELG, VVUS)

    Benzinga
  93. Illumina, Inc. (ILMN) President & CEO Jay T Flatley sells 5, ...

    GuruFocus
  94. The Week Ahead: Earnings from Facebook, Ford, Caterpillar; US ...

    Benzinga
  95. Biogen, Illumina Ready Q4 Reports As Stocks Struggle

    IBD
  96. Life Technologies Stock Hits High On Buyout Rumors

    IBD
  97. Illumina, Inc. (ILMN) President & CEO Jay T Flatley sells 5, ...

    GuruFocus
  98. Benzinga's M&A Chatter for Tuesday January 8, 2013

    Benzinga
  99. Illumina plunges as talks falter

    IBD
  100. Benzinga's M&A Chatter for Monday January 7, 2013

    Benzinga
Trading Center